|
|
Article: B-M S and Otsuka launch Abilify Discmelt.(Bristol-Myers Squibb and Otsuka Pharmaceutical Co product introduction )(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- September 4, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
US drugmaker Bristol-Myers Squibb and Japan's Otsuka Pharmaceutical have announced the launch of an orally disintegrating tablet version of their co-developed antipsychotic Abilify (arpiprazol), known as Abilify Discmelt. This follows the US Food and Drug Administration approval of the product in June this year.
The firms explained that the product, which is a vanilla flavored tablet, available in 10mg and 15mg dosages, was designed as a convenient alternative for schizophrenic ...